Massachusetts Financial Services’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-57,411
| Closed | -$239K | – | 919 |
|
|
2024
Q3 | $239K | Sell |
57,411
-1,390
| -2% | -$5.78K | ﹤0.01% | 834 |
|
|
2024
Q2 | $321K | Sell |
58,801
-180,030
| -75% | -$983K | ﹤0.01% | 839 |
|
|
2024
Q1 | $2.39M | Sell |
238,831
-814,499
| -77% | -$8.14M | ﹤0.01% | 720 |
|
|
2023
Q4 | $4.3M | Sell |
1,053,330
-6,810
| -0.6% | -$27.8K | ﹤0.01% | 667 |
|
|
2023
Q3 | $4.1M | Sell |
1,060,140
-8,047
| -0.8% | -$31.1K | ﹤0.01% | 667 |
|
|
2023
Q2 | $6.37M | Sell |
1,068,187
-14,257
| -1% | -$85K | ﹤0.01% | 631 |
|
|
2023
Q1 | $3.54M | Buy |
1,082,444
+29,872
| +3% | +$97.7K | ﹤0.01% | 662 |
|
|
2022
Q4 | $4.16M | Buy |
1,052,572
+234,549
| +29% | +$926K | ﹤0.01% | 665 |
|
|
2022
Q3 | $4.91M | Buy |
818,023
+55,407
| +7% | +$332K | ﹤0.01% | 652 |
|
|
2022
Q2 | $4.9M | Sell |
762,616
-5,728
| -0.7% | -$36.8K | ﹤0.01% | 653 |
|
|
2022
Q1 | $6.35M | Buy |
768,344
+21,230
| +3% | +$175K | ﹤0.01% | 661 |
|
|
2021
Q4 | $11.6M | Sell |
747,114
-5,499
| -0.7% | -$85.1K | ﹤0.01% | 651 |
|
|
2021
Q3 | $16.9M | Buy |
752,613
+266,829
| +55% | +$6.01M | 0.01% | 626 |
|
|
2021
Q2 | $9.55M | Sell |
485,784
-1,382
| -0.3% | -$27.2K | ﹤0.01% | 676 |
|
|
2021
Q1 | $16.3M | Buy |
+487,166
| New | +$16.3M | 0.01% | 626 |
|